ArticlePloS one2024

Targeting the adenosinergic system in restless legs syndrome: A pilot, "proof-of-concept" placebo-controlled TMS-based protocol.

Giuseppe Lanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.